TITLE
Glycogen synthase kinase 3 inhibitor effect on MLL leukemia cells

SUMMARY
Analysis of MLL leukemia cell line RS4.11 treated with GSK-3 inhibitor SB216763 for 20 hours. Results provide insight into the molecular mechanisms underlying MLL leukemia dependence on GSK-3.

ORGANISM
Homo sapiens

